Editorial
A Back to the Bottom Story of Rectal Cancer Surgery
Francis Seow-Choen**
Seow-Choen Colorectal Surgery Centre, Singapore
*Corresponding author: Francis Seow-Choen, Seow-Choen Colorectal Surgery Centre, 290 Orchard Road Paragon, #06-06 Singapore
Published: 02 Nov, 2016
Cite this article as: Seow-Choen F. A Back to the Bottom
Story of Rectal Cancer Surgery. Clin
Surg. 2016; 1: 1171.
Introduction
In the early days rectal cancer surgeries were performed via the perineum [1]. Such surgery was fraught with danger, and surgical mortality was inevitably high. Abdominal perineal resection first described by Miles in 1908 [2] was associated with an operative mortality of up to 42%. Subsequent improvements in perioperative care brought this high mortality rate down considerably. Thereafter, abdominoperineal resection became the standard treatment for almost all rectal cancers until Dixon described anterior resection for proximal rectal cancers in 1939 [3]. Since that time numerous improvements in surgical technique had been described for resection of the rectum resulting in safer and more radical surgery.
Advances in Rectal Cancer Surgery
Two of the most important surgical innovations since that time were the understanding of the
importance of total mesorectal excision (TME) proposed by Bill Heald in 1982 [4] for open rectal
surgery and the explosion of minimal access approaches for resection of rectal cancer beginning
from the 1990s.
The concept of TME taught surgeons the importance of respecting the embryonic and anatomical
planes during rectal resection. TME or a complete and technically skilful resection of the rectum plus
the entire enveloping mesorectal fascia ensures that the enclosed rectal cancer and all the potentially
involved lymph nodes are completely removed. An incompletely performed TME runs the risk of
leaving involved lymph nodes behind or else allow leaking lymphatic’s to seed cancer cells into the
pelvis leading to increased risk of local recurrence. Therefore when radical surgery for rectal cancer
is contemplated, the TME technique should always be routinely performed.
Minimally Invasive Techniques
The advent of laparoscopy and robotic surgery in the management of rectal cancer is another
very significant milestone in the management of rectal cancers. The initial reported increased
incidence of wound or port site cancer implantation following laparoscopic techniques in rectal
cancer had now been shown not to be an issue with this technique if properly performed [5].
Laparoscopic resection of rectal cancers is routine in many colorectal departments around
the world. This is especially true of mid and high rectal cancers as these are usually mobilised and
removed without too much difficulty via what is now known as traditional laparoscopic methods [6].
Very low rectal cancers however may not be so easily removed via laparoscopic methods especially
in obese males with a very narrow pelvis.
The use of robotic techniques therefore in such patients may therefore bring great advantages
due to the configuration of the robotic set-up and instrumentation [7]. The use of the robot in very
low rectal cancers may enable the difficult mobilization of the last few centimetres of lower rectum
to be performed with ease.
Nonetheless whichever method, open, laparoscopic or robotic methods are used to perform
TME in a patient with a low rectal cancer; especially in a male obese patient with a largish cancer;
the ability to get beyond the cancer may be a great challenge. Furthermore the adequacy of a clear
distal margin beyond the cancer may sometimes be found compromised only after the distal rectum
had been transected. This will make a difficult surgery even more challenging for the surgeon and
may be disastrous for the patient by increasing the risk of local recurrence beyond what is present
if this margin was clear.
Reverse or Transanal TME
This brings us to the next advancement in minimally invasive rectal cancer surgery. The use of
the transrectal or transanal or reverse TME techniques [8] as it had been variously called had been
attributed to Lacy in 2011. However it was actually first practised
as the TATA or transabdominal transanal operation by Marks
[9]. This technique enables the surgeon to secure the distal margin
beyond a difficult large and low rectal cancer. The distal margin can
be ascertained and after closure to prevent tumour cell seedling the
distal resection margin ca n be made. Because this resection is done
under direct vision, a clear distal margin can be assured unlike that
during a totally abdominal approach. This is a logical and important
innovation in enabling rectal surgeons to secure a cancer free distal
margin and will help more patients to avoid a permanent stoma in
low rectal cancers.
These minimally invasive techniques bring several advantages to
patients including a dramatic decrease in post operative pain, hospital
stay and improved return to normal activities of life. However there
are surgeons who have attempted incision less surgery or natural
orifice surgery with natural orifice specimen extraction for this
low rectal cancer. They therefore perform ligation of the inferior
mesenteric vessels as well as a complete TME via the anus. The
future will tell if this technique brings added advantage to patients.
For the moment it seems that all this latter technique does is make
a simple transabdominal ligation of the inferior mesenteric vessels,
mobilization of the left colon and splenic flexure as well as upper rectal
and mesorectal mobilization much more difficult and dangerous.
Most practitioners however, actually perform the so called reverse
or transanal TME via two steps. Firstly via an abdominal minimally
invasive approach via either laparoscopy or robotic techniques. Here
the upper and middle rectum and mesorectum are fully mobilised
transabdominally. Once the rectum is mobilized as inferiorly as
possible, the operator proceeds to do the transanal mobilization of
the inferior rectum and its mesorectum. It therefore is usually not
really a transanal or reverse TME as such.
Conclusion
Reverse TME or transanal TME as usually performed should therefore not be called as such but a transanal assisted transabdominal TME.
References
- Breen RE, Garnjobst W. Surgical procedures for carcinoma of the rectum. A historical review. Dis Colon Rectum 1983; 26: 680–685.
- Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908; 2: 1812–1813.
- Dixon CF. Surgical removal of lesions occurring in the sigmoid and rectosigmoid. Am J Surg. 1939; 46: 12-17.
- Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg. 1982; 69: 613-616
- Bărbulescu M, Alecu L, Boeţi P, Popescu I. Port-site metastasis after laparoscopic surgry for colorectal cancer-still a real concern? Case report and review of the literture. Chirurgia (Bucur). 2012; 107: 103-107.
- Seow-Choen F. Ultra-low anterior resection for low rectal cancer: five key tips to make it easy. Tech Coloproctol. 2009; 13: 89-93.
- Feroci F, Vannucchi A, Bianchi PP, Cantafio S, Garzi A, Formisano G, et al. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery. World J Gastroenterol. 2016: 22: 3602-3610.
- Lacy AM, Adelsdorfer C. Totally transrectal endoscopic total mesorectal excision (TME) Colorectal Dis. 2011: 13: 43-46.
- Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002; 95: 1144-1150.